---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-014209"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T08:37:15.617242+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE posts record Q4 revenue $10.3M, FY rev $32.6M; guides 47-53% growth in FY2025

## Summary
- Q4 2024 revenue $10.3M (+47% YoY); full year $32.6M (+60% YoY), both all-time records.
- Gross margin improved to 77.9% (Q4) and 75.2% (FY); operating income $2.5M (Q4) and $5.4M (FY).
- Adjusted EBITDA $3.7M in Q4 (vs $0.7M) and $7.2M for FY (vs -$1.2M), positive cash flow from operations.
- Net loss $31.4M for FY driven by derivative liability fair value changes; capital structure simplified.
- Guidance: Q1 2025 rev $8.4-9.0M (+45-55%); FY2025 rev $48-50M (+47-53%).

## SEC filing metadata
- accession: 0001628280-25-014209
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/0001628280-25-014209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025014209/snwv-20250321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-014209
- JSON: https://secwatch.observer/filing/0001628280-25-014209.json
- Plain text: https://secwatch.observer/filing/0001628280-25-014209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.